SG11202108863WA - Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof - Google Patents
Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereofInfo
- Publication number
- SG11202108863WA SG11202108863WA SG11202108863WA SG11202108863WA SG11202108863WA SG 11202108863W A SG11202108863W A SG 11202108863WA SG 11202108863W A SG11202108863W A SG 11202108863WA SG 11202108863W A SG11202108863W A SG 11202108863WA SG 11202108863W A SG11202108863W A SG 11202108863WA
- Authority
- SG
- Singapore
- Prior art keywords
- octanylmethanone
- diazabicyclo
- pyrimidinyl
- crystalline
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962806180P | 2019-02-15 | 2019-02-15 | |
PCT/IB2020/051128 WO2020165788A1 (en) | 2019-02-15 | 2020-02-12 | Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202108863WA true SG11202108863WA (en) | 2021-09-29 |
Family
ID=69726639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202108863WA SG11202108863WA (en) | 2019-02-15 | 2020-02-12 | Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220144846A1 (es) |
EP (1) | EP3924355A1 (es) |
JP (1) | JP2020138960A (es) |
KR (1) | KR20210114470A (es) |
CN (1) | CN113646310A (es) |
AR (1) | AR118099A1 (es) |
AU (1) | AU2020222083B2 (es) |
BR (1) | BR112021015951A2 (es) |
CA (1) | CA3130034C (es) |
MX (1) | MX2021009761A (es) |
SG (1) | SG11202108863WA (es) |
TW (1) | TWI820301B (es) |
WO (1) | WO2020165788A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021249367A1 (zh) * | 2020-06-09 | 2021-12-16 | 苏州晶云药物科技股份有限公司 | 二氮杂双环类化合物的对甲苯磺酸盐新晶型及其制备方法 |
CN114835717A (zh) * | 2021-02-01 | 2022-08-02 | 杭州领业医药科技有限公司 | Brepocitinib甲苯磺酸盐的晶型及其制备方法和用途 |
CN113461687B (zh) * | 2021-08-10 | 2022-04-19 | 四川大学华西医院 | 2,8-氮杂-[4,5]十螺环酮衍生物及其制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
SI3290421T1 (sl) | 2013-02-22 | 2019-03-29 | Pfizer Inc. | Kombinacija derivatov pirolo (2,3-D)pirimidina z enim ali več dodatnimi sredstvi za zaviranje z janusom povezane kinaze (JAK) |
NO2721710T3 (es) * | 2014-08-21 | 2018-03-31 |
-
2020
- 2020-02-12 WO PCT/IB2020/051128 patent/WO2020165788A1/en active Application Filing
- 2020-02-12 CN CN202080028910.4A patent/CN113646310A/zh active Pending
- 2020-02-12 CA CA3130034A patent/CA3130034C/en active Active
- 2020-02-12 KR KR1020217025620A patent/KR20210114470A/ko active IP Right Grant
- 2020-02-12 BR BR112021015951-7A patent/BR112021015951A2/pt unknown
- 2020-02-12 US US17/430,373 patent/US20220144846A1/en active Pending
- 2020-02-12 AU AU2020222083A patent/AU2020222083B2/en active Active
- 2020-02-12 MX MX2021009761A patent/MX2021009761A/es unknown
- 2020-02-12 SG SG11202108863WA patent/SG11202108863WA/en unknown
- 2020-02-12 TW TW109104358A patent/TWI820301B/zh active
- 2020-02-12 EP EP20708183.7A patent/EP3924355A1/en active Pending
- 2020-02-12 JP JP2020021119A patent/JP2020138960A/ja active Pending
- 2020-02-14 AR ARP200100415A patent/AR118099A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN113646310A (zh) | 2021-11-12 |
EP3924355A1 (en) | 2021-12-22 |
TWI820301B (zh) | 2023-11-01 |
WO2020165788A1 (en) | 2020-08-20 |
CA3130034A1 (en) | 2020-08-20 |
KR20210114470A (ko) | 2021-09-23 |
JP2020138960A (ja) | 2020-09-03 |
AU2020222083B2 (en) | 2022-11-17 |
AR118099A1 (es) | 2021-09-15 |
TW202045511A (zh) | 2020-12-16 |
US20220144846A1 (en) | 2022-05-12 |
CA3130034C (en) | 2023-12-19 |
BR112021015951A2 (pt) | 2021-10-05 |
AU2020222083A1 (en) | 2021-09-02 |
MX2021009761A (es) | 2021-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288816A (en) | Aminobenzazepine compounds, immunoconjugates and uses thereof | |
IL276802A (en) | Transduced 2,1-dihydro-3h-pyrazolo[4,3-d]pyrimidin-3-ones | |
EP3972967A4 (en) | HETEROCYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USES | |
EP4077311A4 (en) | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION PROCESSES AND THEIR USES | |
IL291033A (en) | rip1 inhibitory compounds and methods for their preparation and use | |
HUE054690T2 (hu) | 8-Oxetán-3-il-3,8-diazabiciklo[3.2.1]oktán-3-il-csoporttal szubsztituált vegyületek HIV inhibitorokként | |
IL285302A (en) | Compounds, preparations and methods | |
EP3774027A4 (en) | ELECTRIC CATALYSTS, THEIR PRODUCTION AND USE FOR AMMONIA SYNTHESIS | |
EP3782998A4 (en) | SUBSTITUTED PYRROLOTRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND THEIR USES | |
SG11202108863WA (en) | Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof | |
EP3345900A4 (en) | 2,4-DI (NITROGENIC GROUP) SUBSTITUTED PYRIMIDINE COMPOUND AND METHOD OF PREPARATION AND USE THEREOF | |
IL290781A (en) | rip1 inhibitory compounds and methods for their preparation and use | |
EP3743060A4 (en) | ANTIBACTERIAL COMPOUNDS, RELATED COMPOSITIONS AND THEIR METHODS OF USE | |
IL284765A (en) | 8,1-naphthyridinone compounds and their uses | |
EP3846791A4 (en) | ILLUDIN ANALOGUES, THEIR USES AND PROCEDURES FOR THEIR SYNTHESIS | |
IL287120A (en) | Compounds, preparations and methods | |
EP3845538A4 (en) | DIHYDROIMIDAZOPYRAZINONE COMPOUND, COMPOSITIONS THEREOF, AND USES THEREOF | |
EP3793550A4 (en) | SUBSTITUTED 2,2' BIPYRIMIDINYL COMPOUNDS, ANALOGS THEREOF AND METHODS THEREOF | |
ZA202107832B (en) | Pyrrole amidopyridone compound, preparation method therefor and use thereof | |
EP3872065A4 (en) | SULFOBIPHENYL COMPOUND, METHOD OF PRODUCTION THEREOF AND USES THEREOF | |
SG11202008531RA (en) | Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof | |
PL3750893T3 (pl) | Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania | |
IL282999A (en) | 4,3,1-oxadiazolone compound and drug | |
EP4007578A4 (en) | SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGS THEREOF AND METHODS THEREOF | |
EP3932909A4 (en) | BENZOINDAZOLON COMPOUND AND INTERMEDIATE THEREOF |